Ozmosi
Analysis completed on 3/24/2026
Ozmosi operates in a high-value B2B niche (pharma data and consulting) and has demonstrated longevity since 2013 with a 30-person team. However, the submission itself is extremely poor quality, featuring impossible claims (e.g., 'most people have used my product') and contradictory metrics ('everyone' audience reach for a highly specialized firm). The strong market relevance and utility base scores are heavily penalized by the 0.5 quality factor due to these vague and unsubstantiated responses.
Ready to Compete for $150k+ in Prizes?
Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes
Score Breakdown
Project Details
Algorithm Insights
Recommendations to Increase Usefulness Score
Document User Growth
Provide specific metrics on user acquisition and retention rates
Showcase Revenue Model
Detail sustainable monetization strategy and current revenue streams
Expand Evidence Base
Include testimonials, case studies, and third-party validation
Technical Roadmap
Share development milestones and feature completion timeline